发明授权
US08030097B2 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
有权
Lipocalin-2作为心脏和卒中风险的预后和诊断标记
- 专利标题： Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
- 专利标题（中）： Lipocalin-2作为心脏和卒中风险的预后和诊断标记
-
申请号： US12113056申请日： 2008-04-30
-
公开(公告)号： US08030097B2公开(公告)日： 2011-10-04
- 发明人: Aimin Xu , Yu Wang , Reinhard Renneberg , George William Hunter Cautherley , Cangel Pui Yee Chan , Matthias Lehmann
- 申请人： Aimin Xu , Yu Wang , Reinhard Renneberg , George William Hunter Cautherley , Cangel Pui Yee Chan , Matthias Lehmann
- 申请人地址： CN Hong Kong
- 专利权人： Versitech Limited and R & C Biogenius Limited
- 当前专利权人： Versitech Limited and R & C Biogenius Limited
- 当前专利权人地址： CN Hong Kong
- 代理机构： Saliwanchik, Lloyd & Eisenschenk
- 主分类号： G01N33/53
- IPC分类号： G01N33/53
摘要：
Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluids (including but not limited to blood, serum, plasma, urine, saliva, tear, etc.) by an assay such as an immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases; and (2) the determination of the likelihood that certain individuals will benefit to a greater or lesser extent from the use of certain treatments designed to prevent and/or treat cardiovascular diseases.
公开/授权文献
信息查询
IPC分类:
